HomeBusiness NewsAmplia targets ovarian cancer in new clinical protein inhibitor trial

Amplia targets ovarian cancer in new clinical protein inhibitor trial

May 8, 2026

- Advertisement -

Brought to you by BULLS N’ BEARSMurray WardMay 8, 2026 — 1:57pmSaveYou have reached your maximum number of saved items.Remove items from your saved list to add more.AAAASX-listed Amplia Therapeutics is aggressively broadening its clinical reach, unveiling a major new collaboration to throw…

Click here to view the original article.

Tags
Brisbanetimes.com.au

- Advertisment -

SWIMMA survey demonstrates overwhelming need for year-round aquatic facility

It’s not one size fits all – Local composters say no to FOGO

Amplia targets ovarian cancer in new clinical protein inhibitor trial

Recently Viewed

The pianist from the audience at La La Land in Concert was a global feelgood story – but all was not what it seemed...

Collingwood superstar Nick Daicos on collision course with first Brownlow Medal

From ship to sharpshooter: inside double life of this key position Demon

AFL hands down verdict on Hawks defender Josh Weddle’s jaw-breaking bump on Daniel Rioli

FEATURED

Great White shark bites fishing boat off Sunshine Coast

Volcanic cloud from Whakaari White Island halts flights

Great Koala Count: Aussies urged to track sightings of iconic marsupials

POPULAR POSTS

Households lead march to least-cost electricity, as AEMO issues “call to arms” on renewable transition

Larry Ellison and David MacNeil Split a $67M Waterfront Site in Manalapan

Syntax Bio Announces Expanded Series A and Leadership Appointments

POPULAR CATEGORY

FOLLOW US

Amplia targets ovarian cancer in new clinical protein inhibitor trial

RELATED ARTICLES

Recently Viewed

FEATURED

POPULAR POSTS

POPULAR CATEGORY

FOLLOW US